WAF1/CIP1 is Induced in P53-mediated G1 Arrest and Apoptosis
Overview
Authors
Affiliations
The tumor growth suppressor WAF1/CIP1 was recently shown to be induced by p53 and to be a potent inhibitor of cyclin-dependent kinases. In the present studies, we sought to determine the relationship between the expression of WAF1/CIP1 and endogenous regulation of p53 function. WAF1/CIP1 protein was first localized to the nucleus of cells containing wild-type p53 and undergoing G1 arrest. WAF1/CIP1 was induced in wild-type p53-containing cells by exposure to DNA damaging agents, but not in mutant p53-containing cells. The induction of WAF1/CIP1 protein occurred in cells undergoing either p53-associated G1 arrest or apoptosis but not in cells induced to arrest in G1 or to undergo apoptosis through p53-independent mechanisms. DNA damage led to increased levels of WAF1/CIP1 in cyclin E-containing complexes and to an associated decrease in cyclin-dependent kinase activity. These results support the idea that WAF1/CIP1 is a critical downstream effector in the p53-specific pathway of growth control in mammalian cells.
Haddad A, Golan-Lev T, Benvenisty N, Goldberg M Mol Med. 2025; 31(1):97.
PMID: 40082762 PMC: 11907909. DOI: 10.1186/s10020-025-01141-5.
AMH protects the ovary from doxorubicin by regulating cell fate and the response to DNA damage.
Nguyen N, Chang E, Chauvin M, Sicher N, Kashiwagi A, Nagykery N Proc Natl Acad Sci U S A. 2025; 122(5):e2414734122.
PMID: 39874288 PMC: 11804487. DOI: 10.1073/pnas.2414734122.
Multicellular model of neuroblastoma proposes unconventional therapy based on multiple roles of p53.
Wertheim K, Chisholm R, Richmond P, Walker D PLoS Comput Biol. 2024; 20(12):e1012648.
PMID: 39715281 PMC: 11723635. DOI: 10.1371/journal.pcbi.1012648.
Pro-survival roles for p21(Cip1/Waf1) in non-small cell lung cancer.
Cutty S, Hughes F, Ortega-Prieto P, Desai S, Thomas P, Fets L Br J Cancer. 2024; 132(5):421-437.
PMID: 39706988 PMC: 11876327. DOI: 10.1038/s41416-024-02928-9.
Emerging insights in senescence: pathways from preclinical models to therapeutic innovations.
Mansfield L, Ramponi V, Gupta K, Stevenson T, Mathew A, Barinda A NPJ Aging. 2024; 10(1):53.
PMID: 39578455 PMC: 11584693. DOI: 10.1038/s41514-024-00181-1.